NCT05144724

Brief Summary

This is a pilot trial to assess the feasibility of volume Targeted Ventilation in the Delivery Room. Preterm infants will be randomized to pressure guided or volume targeted ventilation during respiratory support in the delivery room

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 3, 2021

Completed
2.8 years until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2025

Completed
Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

October 21, 2021

Last Update Submit

January 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of of eligible participants (=infants requiring PPV) who have the intervention performed correctly without protocol deviation (=cross over to control group when randomized to VTV-group)

    Percentage of Participants who have received allocated treatment

    Through study completion (total 18 months)

Secondary Outcomes (15)

  • Number of participants with mortality

    up to 6 months of NICU admission

  • Number of participants with severe brain injury on cranial ultrasound

    up to 6 months of NICU admission

  • Number of participants with severe retinopathy of prematurity (stage 3 or higher)

    up to 6 months of NICU admission

  • Number of participants with bronchopulmonary dysplasia at 36 weeks corrected age

    At 36 weeks corrected age

  • Number of participants with Bronchopulmonary dysplasia at 40 weeks corrected age

    At 40 weeks corrected age

  • +10 more secondary outcomes

Other Outcomes (2)

  • Resuscitators subjective workload performing mask ventilation

    within the first 10 min after birth

  • Resuscitators qualitative feedback on using VTV-PPV in the delivery room

    within the first 10 min after birth

Study Arms (2)

Volume Targeted Ventilation

EXPERIMENTAL

Positive pressure ventilation will be provided using a set tidal volume

Procedure: Volume targeted ventilation

Pressure guided Ventilation

ACTIVE COMPARATOR

Positive pressure ventilation will be provided using a set peak inflation pressure

Procedure: Pressure targeted ventilation

Interventions

Positive pressure ventilation will be provided using a set tidal volume

Volume Targeted Ventilation

Positive pressure ventilation will be provided using a set peak inflation pressure

Pressure guided Ventilation

Eligibility Criteria

Age0 Minutes - 1 Minute
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Born between 23+0/7 to 28+6/7 weeks' gestation
  • Considered suitable for full resuscitation, i.e., no parental request or antenatal decision to forego resuscitation
  • Informed parental consent

You may not qualify if:

  • Major congenital or chromosomal malformation
  • Conditions that might have an adverse effect on breathing or ventilation (e.g., high risk for lung hypoplasia, congenital diaphragmatic hernia)
  • Congenital heart disease requiring intervention in the neonatal period
  • Hydrops requiring intervention in the neonatal period
  • Neonatal resuscitation initiated before NICU team arrival
  • Infants who are born outside of study center and transported to center after delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Alexandra Hospital

Edmonton, Alberta, T5H 3V9, Canada

Location

Related Publications (1)

  • Law BHY, Yaskina M, Davis PG, Polglase G, Dunn M, Mukerji A, Schmolzer GM. Study protocol for the volume targeted mask ventilation versus pressure ventilation in preterm infants-the VOLT-trial. Front Pediatr. 2026 Jan 6;13:1743460. doi: 10.3389/fped.2025.1743460. eCollection 2025.

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Georg Schmölzer, MD, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2021

First Posted

December 3, 2021

Study Start

October 1, 2024

Primary Completion

October 30, 2025

Study Completion

December 17, 2025

Last Updated

January 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

The protocol will be published in an open access journal and data can be requested from the principal investigator

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Protocol will be published within 18 months

Locations